Abstract:INTRODUCTION: A variety of factors have been identified in the literature which influence survival following resection of colorectal liver metastases (CRLM). Much of this literature is historical, and its relevance to contemporary practice is not known. The aim of this study was to identify those factors which influence survival during the era of preoperative chemotherapy in patients undergoing resection of CRLM in a UK centre.METHODS: All patients having liver resection for CRLM during an 11-year period up to 2011 were identified from a prospectively maintained database. Prognostic factors analysed included tumour size (≥5 or <5 cm), lymph node status of the primary tumour, margin positivity (R1; <1 mm), neo-adjuvant chemotherapy (for liver), tumour differentiation, number of liver metastases (≥4), preoperative carcinoembryonic antigen (CEA; ≥200 ng/ml) and whether metastases were synchronous (i.e. diagnosed within 12 months of colorectal resection) or metachronous to the primary tumour. Overall survival (OS) was compared using Kaplan-Meier plots and a log rank test for significance. Multivariate analysis was performed using a Cox regression model. Statistical analysis was performed in SPSS v19, and p < 0.05 was considered to be significant.RESULTS: 432 patients underwent resection of CRLM during this period (67% male; mean age 64.5 years), and of these, 54 (13.5%) had re-resections. The overall 5-year survival in this series was 43% with an actuarial 10-year survival of 40%. A preoperative CEA ≥200 ng/ml was present in 10% of patients and was associated with a poorer 5-year OS (24 vs. 45%; p < 0.001). A positive resection margin <1 mm was present in 16% of patients, and this had a negative impact on 5-year OS (15 vs. 47%; p < 0.001). Tumour differentiation, number, biliary or vascular invasion, size, relationship to primary disease, nodal status of the primary disease or the use of neo-adjuvant chemotherapy had no impact on OS. Multivariate analysis identified only the presence of a positive resection margin (OR 1.75; p < 0.05) and a preoperative CEA ≥200 ng/ml (OR 1.88; p < 0.01) as independent predictors of poor OS.CONCLUSION: Despite the wide variety of prognostic factors reported in the literature, this study was only able to identify a preoperative CEA ≥200 ng/ml and the presence of tumour within 1 mm of the resection margin as being of value in predicting survival. These variables are likely to identify patients who may benefit from intensive follow-up to enable early aggressive treatment of recurrent disease.

Liver resection for colorectal metastases: results and prognostic factors with 10-year follow-up

Survival and Prognostic Factors of Colorectal Liver Metastases after Surgical and Nonsurgical Treatment.

Predicting 10-year survival after resection of colorectal liver metastases; an international study including biomarkers and perioperative treatment

Outcome of Patients with Colorectal Liver Metastasis: Analysis of 1,613 Consecutive Cases.

Outcome of Patients with Colorectal Liver Metastasis: Analysis of 1613 Consecutive Cases

Survival Investigation in Patients with Colorectal Liver Metastasis: A Single-Institution Analysis.

Long-term postoperative survival prediction in patients with colorectal liver metastasis.

Prognosis and risk factors after surgical treatment for colorectal cancer liver metastases

Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection

Letter Re: Predicting 10-Year Survival after Resection of Colorectal Liver Metastases: an International Study Including Biomarkers and Perioperative Treatment

Analysis of prognostic factors after resection of solitary liver metastasis in colorectal cancer: a 22-year bicentre study

Long-term survival and cure model following liver resection for breast cancer metastases

Long-Term Outcome After Resection of Hepatic and Pulmonary Metastases in Multivisceral Colorectal Cancer

Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients

Predictors and outcomes of recurrence after resection of colorectal liver metastases]

Prognostic Factors and Survival after Resection of Colorectal Liver Metastasis in the Era of Preoperative Chemotherapy: An 11-Year Single-Centre Study

Prognostic analysis of 669 liver metastasis of colorectal cancer cases

[Evaluation of Long-Term Survival after Hepatic Resection for Metastatic Colorectal Cancer-a Multifactorial Model of 191 Patients].

[Analysis of Long-Term Outcomes and Risk Factors in Patients Undergoing Simultaneous Resection of Synchronous Colorectal Liver Metastasis].

Long-Term Outcomes after Surgical Resection for Synchronous or Metachronous Hepatic and Pulmonary Colorectal Cancer Metastases

[Survival Status and Prognostic Factors of Liver Metastases from Colorectal Cancer].